Goldman Sachs’s Oruka Therapeutics, Inc. Common Stock ORKA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $810K | Sell |
72,249
-171,950
| -70% | -$1.93M | ﹤0.01% | 3969 |
|
|
2025
Q1 | $2.51M | Buy |
+244,199
| New | +$2.51M | ﹤0.01% | 3209 |
|
|
2021
Q3 | – | Sell |
-1,160
| Closed | -$49K | – | 5563 |
|
|
2021
Q2 | $49K | Buy |
+1,160
| New | +$49K | ﹤0.01% | 5243 |
|
|
2021
Q1 | – | Sell |
-2,525
| Closed | -$121K | – | 5388 |
|
|
2020
Q4 | $121K | Buy |
+2,525
| New | +$121K | ﹤0.01% | 4438 |
|
|
2017
Q3 | – | Sell |
-75
| Closed | -$39K | – | 4431 |
|
|
2017
Q2 | $39K | Sell |
75
-2
| -3% | -$1.04K | ﹤0.01% | 4275 |
|
|
2017
Q1 | $43K | Sell |
77
-17
| -18% | -$9.49K | ﹤0.01% | 4237 |
|
|
2016
Q4 | $58K | Sell |
94
-8
| -8% | -$4.94K | ﹤0.01% | 4215 |
|
|
2016
Q3 | $62K | Buy |
102
+51
| +100% | +$31K | ﹤0.01% | 4269 |
|
|
2016
Q2 | $32K | Buy |
+51
| New | +$32K | ﹤0.01% | 4336 |
|
|
2014
Q4 | – | Sell |
-8
| Closed | -$15K | – | 4696 |
|
|
2014
Q3 | $15K | Sell |
8
-2
| -20% | -$3.75K | ﹤0.01% | 4474 |
|
|
2014
Q2 | $22K | Buy |
+10
| New | +$22K | ﹤0.01% | 4346 |
|